Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’

Published on 16 Jan 2025 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In...

Insider Monkey · via Yahoo Finance 16 Jan 2025

Tourlite Capital Management, an investment management firm, released its third quarter 2024 inves...

Insider Monkey · via Yahoo Finance 6 Dec 2024

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus ...

Insider Monkey via Yahoo Finance 4 May 2024

Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders are probably feeling a little disappoint...

Simply Wall St. via Yahoo Finance 3 Mar 2024

Today is shaping up negative for Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders, with t...

Simply Wall St. via Yahoo Finance 2 Mar 2024

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024 Ar...

Insider Monkey via Yahoo Finance 1 Mar 2024

Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders should be happy to see the share price u...

Simply Wall St. via Yahoo Finance 31 Jan 2024

Key Insights Significant control over Arbutus Biopharma by individual investors implies that the ...

Simply Wall St. via Yahoo Finance 1 Jan 2024

Celebrations may be in order for Arbutus Biopharma Corporation (NASDAQ:ABUS) shareholders, with t...

Simply Wall St. via Yahoo Finance 9 Nov 2023

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript November 7, 2023 Arb...

Insider Monkey via Yahoo Finance 9 Nov 2023